Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation

Abroad (travel likely)RecruitingPHASE4

Conditions

Acute B-cell Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Zhengzhou University, Zhenzhou, Henan, China
Contact: Study coordinator (Suping ZHANG) · zsp198612@163.com · +8613523510641
Contact: Study coordinator (Zhilei BIAN) · 037166862272

Study leads

Zhilei BIAN
Principal Investigator
The First Affiliated Hospital of Zhengzhou University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Beijing, China

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Lymphoblastic Leukemia · Lymphoblastic Leukemia in Children · Lymphoblastic Leukemia, Acute Adult

Abroad (travel likely)RecruitingPHASE2

Singapore, Singapore · Singapore, Singapore

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Lymphoblastic Leukemia, Acute, Childhood · Lymphoblastic Leukemia · Lymphoblastic Leukemia, Acute Adult

Abroad (travel likely)RecruitingPHASE1

Singapore, Singapore